Morgan Stanley’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93K | Buy |
|
|||||
|
2025
Q1 | $77.5K | Hold |
|
|||||
|
2024
Q4 | $80.1K | Hold |
|
|||||
|
2024
Q3 | $99.7K | Hold |
|
|||||
|
2024
Q2 | $84.4K | Sell |
|
|||||
|
2024
Q1 | $127K | Sell |
|
|||||
|
2023
Q4 | $260K | Buy |
|
|||||
|
2023
Q3 | $114K | Sell |
|
|||||
|
2023
Q2 | $145K | Sell |
|
|||||
|
2023
Q1 | $139K | Sell |
|
|||||
|
2022
Q4 | $184K | Sell |
|
|||||
|
2022
Q3 | $114K | Buy |
|
|||||
|
2022
Q2 | $126K | Buy |
|
|||||
|
2022
Q1 | $151K | Buy |
|
|||||
|
2021
Q4 | $180K | Buy |
|
|||||
|
2021
Q3 | $109K | Sell |
|
|||||
|
2021
Q2 | $121K | Sell |
|
|||||
|
2021
Q1 | $242K | Buy |
|
|||||
|
2020
Q4 | $21K | Buy |
|
|||||
|
2020
Q3 | $6K | Sell |
|
|||||
|
2020
Q2 | $85K | Buy |
|
|||||
|
2020
Q1 | $22K | Buy |
|